These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 38688866)
1. K1 capsule-dependent phage-driven evolution in Escherichia coli leading to phage resistance and biofilm production. Antoine C; Laforêt F; Fall A; Blasdel B; Delcenserie V; Thiry D J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38688866 [TBL] [Abstract][Full Text] [Related]
2. In Vitro Characterization and In Vivo Efficacy Assessment in Antoine C; Laforêt F; Blasdel B; Fall A; Duprez JN; Mainil J; Delcenserie V; Thiry D Viruses; 2021 Oct; 13(10):. PubMed ID: 34696434 [TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA mBio; 2017 Oct; 8(5):. PubMed ID: 29066548 [TBL] [Abstract][Full Text] [Related]
4. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model. Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514 [TBL] [Abstract][Full Text] [Related]
5. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model. Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294 [TBL] [Abstract][Full Text] [Related]
6. Resistance to bacteriophage incurs a cost to virulence in drug-resistant Manley R; Fitch C; Francis V; Temperton I; Turner D; Fletcher J; Phil M; Michell S; Temperton B J Med Microbiol; 2024 May; 73(5):. PubMed ID: 38743467 [No Abstract] [Full Text] [Related]
7. In vitro evaluation of two novel Escherichia bacteriophages against multiple drug resistant avian pathogenic Escherichia coli. Karami M; Goudarztalejerdi A; Mohammadzadeh A; Berizi E BMC Infect Dis; 2024 May; 24(1):497. PubMed ID: 38755537 [TBL] [Abstract][Full Text] [Related]
8. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR mBio; 2017 Oct; 8(5):. PubMed ID: 29089428 [TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Identification of Fitness Factors in Mastitis-Associated Escherichia coli. Olson MA; Siebach TW; Griffitts JS; Wilson E; Erickson DL Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29101196 [TBL] [Abstract][Full Text] [Related]
11. Transposable Element Insertions into the Escherichia coli Polysialic Acid Gene Cluster Result in Resistance to the K1F Bacteriophage. Styles KM; Locke RK; Cowley LA; Brown AT; Sagona AP Microbiol Spectr; 2022 Jun; 10(3):e0211221. PubMed ID: 35467398 [TBL] [Abstract][Full Text] [Related]
12. Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae. Han P; Pu M; Li Y; Fan H; Tong Y Virol Sin; 2023 Oct; 38(5):801-812. PubMed ID: 37419417 [TBL] [Abstract][Full Text] [Related]
13. In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model. Bull JJ; Otto G; Molineux IJ Antimicrob Agents Chemother; 2012 Feb; 56(2):949-54. PubMed ID: 22106213 [TBL] [Abstract][Full Text] [Related]
14. Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. Lin TL; Hsieh PF; Huang YT; Lee WC; Tsai YT; Su PA; Pan YJ; Hsu CR; Wu MC; Wang JT J Infect Dis; 2014 Dec; 210(11):1734-44. PubMed ID: 25001459 [TBL] [Abstract][Full Text] [Related]
15. Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of Gong Q; Wang X; Huang H; Sun Y; Qian X; Xue F; Ren J; Dai J; Tang F J Virol; 2021 Aug; 95(18):e0092021. PubMed ID: 34191582 [TBL] [Abstract][Full Text] [Related]
16. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation. King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of novel phages for control of multi-drug resistant Escherichia coli O177 on artificially contaminated beef and their potential to disrupt biofilm formation. Montso PK; Mlambo V; Ateba CN Food Microbiol; 2021 Apr; 94():103647. PubMed ID: 33279072 [TBL] [Abstract][Full Text] [Related]
18. Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strain. Kim MS; Kim YD; Hong SS; Park K; Ko KS; Myung H Appl Environ Microbiol; 2015 Feb; 81(3):900-9. PubMed ID: 25416767 [TBL] [Abstract][Full Text] [Related]